Hepatic uptake of technetium-99m HM-PAO in a fetus.

Authors :: Maguire C
Florence S
Powe JE
Zabel PL
Driedger AA
Source :: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 1990 Feb; Vol. 31 (2), pp. 237-9.
Publication Year :: 1990
Abstract: The normal biodistribution of technetium-99m HM-PAO ([99mTc]HM-PAO) includes significant uptake in the brain, liver, and kidneys. A pregnant patient studied with [99mTc] HM-PAO to confirm brain death provided an opportunity to examine the transplacental distribution of this radio-pharmaceutical in the unborn fetus. Uptake in the fetus after transplacental delivery is almost exclusively hepatic with a small amount of biliary excretion.

Subjects :: Adult
Female
Humans
Pregnancy
Radionuclide Imaging
Technetium Tc 99m Exametazime
Brain Death diagnostic imaging
Fetus metabolism
Liver metabolism
Organotechnetium Compounds pharmacokinetics
Oximes pharmacokinetics
Pregnancy Complications diagnostic imaging

Language :: English
ISSN :: 0161-5505
Volume :: 31
Issue :: 2
Database :: MEDLINE
Journal :: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Publication Type :: Academic Journal
Accession number :: 2313364

Tools